Pneumonia vaccine
Showing 1 - 25 of >10,000
Pneumonia, Pneumococcal, Vaccine Trial (Pneumococcal Vaccine Education)
Not yet recruiting
- Pneumonia, Pneumococcal
- Vaccine
- Pneumococcal Vaccine Education
- (no location specified)
Nov 13, 2023
Covid19, Influenza, Pneumonia Trial in Los Angeles (Full VEPMP Intervention, Partial VEPMP Intervention, Delayed VEPMP
Withdrawn
- Covid19
- +3 more
- Full VEPMP Intervention
- +2 more
-
Los Angeles, CaliforniaCharles R. Drew University of Medicine & Science
Aug 17, 2022
Pneumonia, Influenza, Varicella Zoster Trial (Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and
Not yet recruiting
- Pneumonia
- +5 more
- Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination
- (no location specified)
Oct 4, 2023
Learn About The Effects Of Pneumococcal Vaccine In People With
Not yet recruiting
- HIV
- +2 more
- Vaccine Administration
-
New York, New YorkPfizer
Mar 20, 2023
20-Valent Pneumococcal Conjugate Vaccine Against Vaccine-Type
Not yet recruiting
- Pneumonia
- (no location specified)
Jul 6, 2022
Pneumonia Trial in Taizhou (23-valent pneumococcal polysaccharide vaccine, pneumococcal vaccine polyvalent)
Completed
- Pneumonia
- 23-valent pneumococcal polysaccharide vaccine
- pneumococcal vaccine polyvalent
-
Taizhou, Jiangsu, ChinaAb&b Biotechnology Co., Ltd.JS
Apr 13, 2023
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults
Recruiting
- Influenza
- +2 more
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
- High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
-
Oakland, CaliforniaKaiser Permanente Northern California (entire region)
Sep 1, 2023
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
Recruiting
- Immunization; Infection
- +3 more
-
Ankara, Çankaya, TurkeyLokman Hekim University
Dec 22, 2022
Paediatric Pneumococcal Pneumonia in Malaysia Prior to and
Recruiting
- Pneumonia, Pneumococcal
- Pneumonia Childhood
-
Kuala Lumpur, Federal Territory Of Kuala Lumpur, Malaysia
- +2 more
Apr 4, 2022
Covid-19, SARS Pneumonia, Pneumonia, Viral Trial in Bangkok (Normal Saline, NDV-HXP-S vaccine)
Recruiting
- Covid-19
- +3 more
- Normal Saline
- NDV-HXP-S vaccine
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
Mar 13, 2022
COVID-19 Pneumonia, Coronavirus Infections Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08), Inactivated
Recruiting
- COVID-19 Pneumonia
- Coronavirus Infections
- Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08)
- +2 more
-
Seha, Abu Dhab, United Arab EmiratesSheikh Khalifa Medical City
Jan 30, 2023
Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections Trial in Shangqiu (Protein based pneumococcal vaccine(Low
Completed
- Pneumonia
- +2 more
- Protein based pneumococcal vaccine(Low dose)
- +5 more
-
Shangqiu, Henan, ChinaSuixian Center for Disease Control and Prevention
Nov 3, 2022
Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and
Recruiting
- Community Acquired Pneumonia (CAP)
- Urine sample collection
- Saliva collection
-
Getafe, Madrid, Spain
- +5 more
Dec 7, 2022
Pneumococcal Infection, Streptococcus Pneumoniae Infection, Invasive Pneumococcal Disease, Protection Against Trial in Kilifi
Active, not recruiting
- Pneumococcal Infection
- +2 more
- PCV10
- PCV13
-
Kilifi, KenyaKEMRI Wellcome Trust Research Programme
Feb 23, 2022
COVID-19 Pneumonia Trial in Shang Qiu (Experimental Vaccine 1, Experimental Vaccine 2, Experimental Vaccine 3)
Active, not recruiting
- COVID-19 Pneumonia
- Experimental Vaccine 1
- +3 more
-
Shang Qiu, He Nan, ChinaNing ling Center for Disease Control and Prevention
Jul 20, 2022
Immunogenicity, Vaccine Trial in Suzhou (PCV13 PAC study)
Completed
- Immunogenicity, Vaccine
- PCV13 PAC study
-
Suzhou, Jiangsu, ChinaChildren's Hospital of Soochow University
May 10, 2022
Pneumonia, Respiratory Tract Diseases, Respiratory Tract Infections Trial in Puer (PBPV, PPV23)
Not yet recruiting
- Pneumonia
- +2 more
- PBPV
- PPV23
-
Puer, Yunnan, ChinaLancang Lahu Autonomous County Center for Disease Control and Pr
Nov 10, 2022
COVID-19 Breakthrough Infection in Fully Vaccinated People and
Enrolling by invitation
- COVID-19 Pneumonia
- COVID-19
- Pfizer COVID-19 mRNA vaccine
- Moderna COVID-19 mRNA vaccine
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
Influenza and Pneumonia Trial in Taizhou (Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal
Completed
- Influenza and Pneumonia
- Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
- Separate vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
-
Taizhou, Jiangsu, China
- +3 more
Jul 20, 2022
Streptococcus Pneumonia, Vaccine Preventable Disease Trial (PNEUMOSIL®)
Not yet recruiting
- Streptococcus Pneumonia
- Vaccine Preventable Disease
- PNEUMOSIL®
- (no location specified)
Nov 21, 2021
COVID-19, SARS-CoV-2 Pneumonia Trial in Huai'an (Recombinant COVID-19 vaccine (Sf9 cell))
Not yet recruiting
- COVID-19
- SARS-CoV-2 Pneumonia
- Recombinant COVID-19 vaccine (Sf9 cell)
-
Huai'an, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 19, 2022
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023
Pneumonia, Bacterial, Cancer, Pneumococcal Infections Trial in Ankara (vaccine education)
Completed
- Pneumonia, Bacterial
- +2 more
- vaccine education
-
Ankara, TurkeyHacettepe University Faculty of Medicine Department of Medical O
Jan 27, 2022
COPD, Lung Non-Small Cell Carcinoma, Pneumonia Trial in Buffalo (Quality-of-Life Assessment, Questionnaire Administration,
Recruiting
- Chronic Obstructive Pulmonary Disease
- +7 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 20, 2022